Search hospitals > Washington > Seattle
CCOP - Virginia Mason Research Center
Claim this profileSeattle, Washington 98101
Global Leader in Breast Cancer
Global Leader in Type 1 Diabetes
Conducts research for Diabetes
Conducts research for Lung Cancer
Conducts research for Cancer
210 reported clinical trials
5 medical researchers
Summary
CCOP - Virginia Mason Research Center is a medical facility located in Seattle, Washington. This center is recognized for care of Breast Cancer, Type 1 Diabetes, Diabetes, Lung Cancer, Cancer and other specialties. CCOP - Virginia Mason Research Center is involved with conducting 210 clinical trials across 185 conditions. There are 5 research doctors associated with this hospital, such as Huong T. Pham, David Aboulafia, MD, Sandra Lord, MD, and Carla Greenbaum, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
Stage IV
ER negative
2Type 1 Diabetes
Global LeadermIAA positive
IA-2A positive
ICA positive
Top PIs
Huong T. PhamVirginia Mason Medical Center2 years of reported clinical research
Studies Tumors
Studies Lung Cancer
19 reported clinical trials
47 drugs studied
David Aboulafia, MDVirginia Mason Medical Center8 years of reported clinical research
Studies Lymphoma
Studies Sarcoma
12 reported clinical trials
27 drugs studied
Sandra Lord, MDBenaroya Research Institute1 year of reported clinical research
Studies Type 1 Diabetes
Studies Diabetes
6 reported clinical trials
10 drugs studied
Carla Greenbaum, MDBenaroya Research Institute3 years of reported clinical research
Studies Type 1 Diabetes
Studies Diabetes
4 reported clinical trials
4 drugs studied
Clinical Trials running at CCOP - Virginia Mason Research Center
Type 1 Diabetes
Cancer
Hodgkin's Lymphoma
Gastroparesis
Colorectal Cancer
Adenomatous Polyposis
Diabetes
Lymphoma
Lung Cancer
Kaposi Sarcoma
Frexalimab + Insulin
for Type 1 Diabetes
This trial is testing a new drug called frexalimab in young people with newly diagnosed Type 1 Diabetes. The goal is to see if it can help their bodies keep making insulin. The study will compare different doses of the drug to find the safest and most effective amount.
Recruiting0 awards Phase 27 criteria
JAK Inhibitors
for Type 1 Diabetes
This trial is testing two medications, abrocitinib and ritlecitinib, which aim to reduce immune system activity. The study focuses on people who have been recently diagnosed with Stage 3 Type 1 Diabetes. These medications work by calming the immune system to prevent it from attacking insulin-producing cells in the pancreas.
Recruiting0 awards Phase 213 criteria
Rituximab + Abatacept
for Type 1 Diabetes
This trial is testing whether a combination of two drugs, rituximab-pvvr followed by abatacept, can better preserve insulin production in people newly diagnosed with Type 1 Diabetes compared to rituximab-pvvr alone. Rituximab-pvvr works by reducing harmful immune cells, while abatacept helps calm the immune system. The goal is to see if this combination can improve insulin production and overall diabetes management.
Recruiting0 awards Phase 220 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at CCOP - Virginia Mason Research Center?
CCOP - Virginia Mason Research Center is a medical facility located in Seattle, Washington. This center is recognized for care of Breast Cancer, Type 1 Diabetes, Diabetes, Lung Cancer, Cancer and other specialties. CCOP - Virginia Mason Research Center is involved with conducting 210 clinical trials across 185 conditions. There are 5 research doctors associated with this hospital, such as Huong T. Pham, David Aboulafia, MD, Sandra Lord, MD, and Carla Greenbaum, MD.